LGL Partners, LLC
- SEC CIK
- 0001653202
- Latest filing
- Jul 27, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by LGL Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −3,773−100.0% | Sold out | Holders |
| Q4 2024 | 3,773 | $324.6K | <0.1% | −782−17.2% | Reduced | Holders |
| Q3 2024 | 4,555 | $542.4K | 0.1% | −564−11.0% | Reduced | Holders |
| Q2 2024 | 5,119 | $730.7K | 0.1% | −389−7.1% | Reduced | Holders |
| Q1 2024 | 5,508 | $707.2K | 0.1% | +292+5.6% | Added | Holders |
| Q4 2023 | 5,216 | $539.6K | 0.1% | +100+2.0% | Added | Holders |
| Q3 2023 | 5,116 | $465.2K | 0.1% | 00.0% | UnchangedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 2,558 | $414.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,558 | $407.1K | 0.1% | −901−26.0% | Reduced | Holders |
| Q4 2022 | 3,459 | $468.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3,459 | $345.0K | 0.1% | −70−2.0% | Reduced | Holders |
| Q2 2022 | 3,529 | $393.0K | 0.1% | −697−16.5% | Reduced | Holders |
| Q1 2022 | 4,226 | $469.0K | 0.1% | +245+6.2% | Added | Holders |
| Q4 2021 | 3,981 | $446.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 3,981 | $382.0K | 0.2% | −1,926−32.6% | Reduced | Holders |
| Q2 2021 | 5,907 | $495.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2021 | 5,907 | $398.0K | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.